SARAH FLINT: Open Payments
NPI 1942927546 · PEMBROKE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 43 payments from 14 companies in 2025. Trend: 2023 $826 · 2024 $1,298 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $221 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $139 |
| AstraZeneca Pharmaceuticals LP | 5 | $119 |
| Alnylam Pharmaceuticals Inc. | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 6 | $105 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $85 |
| Pacira Pharmaceuticals Incorporated | 1 | $69 |
| PFIZER INC. | 3 | $61 |
| Amgen Inc. | 2 | $40 |
Products named: Wegovy, JARDIANCE, ONPATTRO, LEQVIO, AIRSUPRA, CAMZYOS, Kerendia, Exparel.
Industry payments across MA — which companies pay providers there.
